D56.4
Hereditary persistence of fetal hemoglobin [HPFH]
Clinical Classification Guidelines
Medical Intelligence & Overview
Hereditary Persistence of Fetal Hemoglobin (HPFH) is a rare genetic condition characterized by the continued production of fetal hemoglobin into adulthood. Normally, the body stops producing fetal hemoglobin after birth, replacing it with adult hemoglobin. However, in individuals with HPFH, this switch does not occur completely. This condition typically does not cause health problems and is often discovered incidentally during blood tests. Understanding HPFH can help distinguish it from other hemoglobin disorders and provide reassurance to affected individuals.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting hemoglobin production Inherited pattern from one or both parents Mutations in specific genes responsible for hemoglobin switching, such as the gamma-globin genes
Key Symptoms: Usually asymptomatic and discovered incidentally Normal blood counts in most cases Potential mild anemia in some cases, although rare Possible mild sickling phenomena if co-existing with other hemoglobinopathies
Diagnostic & Treatment
Diagnosis Path: Hemoglobin electrophoresis: reveals elevated levels of fetal hemoglobin (HbF) in adult blood High-performance liquid chromatography (HPLC): quantifies hemoglobin types, confirming increased HbF Genetic testing: identifies mutations in the gamma-globin genes associated with HPFH Family history assessment: understanding inheritance patterns
Treatment Protocols: Regular hematological assessments to monitor hemoglobin levels Patient education to clarify the benign nature of the condition Distinguishing HPFH from other hemoglobinopathies, like sickle cell disease or thalassemia, to avoid unnecessary treatments Genetic counseling may be considered for families with a history of hemoglobin disorders
Clinical Advice & FAQs
Billing Guidance
Is D56.4 a billable ICD-10 code?
Yes, D56.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D56.4?
Clinical documentation must specify the nature of Hereditary persistence of fetal hemoglobin [HPFH] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference